http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005529082-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 |
| filingDate | 2003-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005529082-A |
| titleOfInvention | 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A and other structural pseudopolymorphs |
| abstract | Formula I [Chemical 1] (Wherein S is an organic solvent that is at least partially miscible with water, x is 1, 1.25, 1.5 or 2 and y is 0, 0.5 or 1). is a substantially pure 9-deoxo -9a- aza -9a- methyl -9a- homoerythromycin a like structure pseudo polymorphs, and monoclinic space group P2 1, the following average lattice constant: crystal axis lengths S: a = 15.5 to 17.0 Å, b = 15.5 to 17.0 Å and c = 17.5 to 19.5 Å, and angles between crystal axes: α = γ = 90 ° and β = 106 ° Pseudopolymorph characterized by 112 °. Further, a method of preparing a substantially pure isostructural pseudopolymorph of formula I; a pharmaceutical composition comprising a substantially pure isostructure pseudopolymorph of formula I; and a substance of formula I Disclosed is a method of treating a bacterial infection, protozoal infection or inflammation-related disease comprising administering a pharmaceutical composition comprising an essentially pure isostructural pseudopolymorph. |
| priorityDate | 2002-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.